PI3K Isoform Inhibition Associated with Anti Bcr-Abl Drugs Shows in Vitro Increased Anti-leukemic Activity in Philadelphia Chromosome-positive B-acute Lymphoblastic Leukemia Cell Lines

dc.contributor.authorMcCubrey, James A.
dc.date.accessioned2022-02-04T13:41:40Z
dc.date.available2022-02-04T13:41:40Z
dc.date.issued2017-02-20
dc.identifier.doi10.18632/oncotarget.15542
dc.identifier.issn1949-2553
dc.identifier.urihttp://hdl.handle.net/10342/9623
dc.language.isoen_USen_US
dc.subjectPI3K isoform inhibitionen_US
dc.subjectCT B-acute lymphoblastic leukemia (B-ALL)en_US
dc.subjectB-cell progenitoren_US
dc.titlePI3K Isoform Inhibition Associated with Anti Bcr-Abl Drugs Shows in Vitro Increased Anti-leukemic Activity in Philadelphia Chromosome-positive B-acute Lymphoblastic Leukemia Cell Linesen_US
dc.typeArticleen_US
ecu.journal.issue14en_US
ecu.journal.nameOncotargeten_US
ecu.journal.pages23213-23227en_US
ecu.journal.volume8en_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
McCubreyPI3KisoforminhibitionassociatedwithantiBcrAbldrugs.pdf
Size:
11.04 MB
Format:
Adobe Portable Document Format
Description:
Article